Circulating immune biomarkers correlating with response in patients with metastatic renal cell carcinoma on ...
As multiple front-line immune checkpoint inhibitor (ICI)-based combinations are approved for metastatic renal cell carcinoma, biomarkers predicting for ICI responses are needed past clinical prognostication scores and transcriptome gene expression …